Skip to main content
Clinical Trials/ACTRN12622001015730
ACTRN12622001015730
Recruiting
未知

Australian Stroke Clinical Registry - LIfe after Stroke Tailored Support (A-LISTS) study: mixed methods study with a pilot randomised controlled trial for people living with stroke

The Florey Institute of Neuroscience and Mental Health0 sites100 target enrollmentJuly 20, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Stroke
Sponsor
The Florey Institute of Neuroscience and Mental Health
Enrollment
100
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 20, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Must meet the agreed criteria for ‘high levels of unmet health needs’ provisionally defined as an extreme problem in any EQ5D domain, or have an overall quality of life score of below 60 (Visual Analogue Scale, EQ5D) self\-report on the Australian Stroke Clinical Registry follow\-up survey conducted between 90\-180 days after stroke and will:
  • i) have indicated a willingness to be contacted for further research on the Australian Stroke Clinical Registry follow\-up survey conducted between 90\-180 days after stroke;
  • ii) be aged 18 years and above;
  • iii) have a confirmed acute stroke;
  • iv) be living in the community in a private residence, (i.e., not hospital or high care residential aged care facility or other institution);
  • v) able to participate in English and provide informed consent via a self\-report or appropriate proxy to assist.

Exclusion Criteria

  • i) Australian Stroke Clinical Registry registrants with a transient ischemic stroke (TIA) will be excluded as they are often managed in outpatient stroke services and should not have any residual impairments as the condition is not permanent
  • ii) Have a life threating illnesses and are unlikely to survive to the study endpoint (i.e. 12\-14 weeks post randomisation).

Outcomes

Primary Outcomes

Not specified

Similar Trials